Literature DB >> 17331846

Maintaining hyporesponsiveness and polarization potential of T cells after in vitro mixture of G-CSF mobilized peripheral blood grafts and G-CSF primed bone marrow grafts in different proportions.

Xiao-Jun Huang1, Ying Jun Chang, Xiang Yu Zhao.   

Abstract

BACKGROUND AND OBJECTIVES: Granulocyte colony-stimulating factor (G-CSF) primed bone marrow grafts (G-BM) plus G-CSF mobilized peripheral blood grafts (G-PB) were used successfully in haploidentical transplantation and the incidence of graft-versus-host disease (GVHD) was not higher compared with that in patients with HLA-matched donors. The immunological characteristics of T cells in G-BM and G-PB mixed in vitro in different proportions were investigated. DESIGN AND METHODS: Lymphocyte proliferation ability, interferon-gamma (IFN-gamma) and interleukin-4 (IL-4) secreted by T cells were determined using a monotetrazolium (MTT) assay and sandwich enzyme-linked immunosorbent assay (ELISA), respectively. T cell subgroups, dendritic cells (DC) subsets, and monocytes were analyzed using flow cytometry in steady-state bone marrow (SS-BM), G-PB, and G-BM and calculated in mixture grafts.
RESULTS: The quantities of IFN-gamma and IL-4 secreted by lymphocytes per microliter in the three mixture grafts were 2- to 4-fold lower than in G-PB and 1- to 3-fold higher than in SS-BM and G-BM, while the IL-4/IFN-gamma ratio was higher than SS-BM and G-PB and lower than G-BM, although no significant difference was confirmed. Lymphocyte proliferation ability in the three mixture grafts was comparable to G-BM and significantly lower than SS-BM and G-PB. Lymphocytes, monocytes, T cell subsets, and DC subsets were 2- to 8-fold lower than in G-PB and 2- to 22-fold higher than in SS-BM and G-BM. The DC1/DC2 ratio was significantly higher in SS-BM than G-PB, G-BM, and the three mixture grafts (P<0.05). INTERPRETATION AND
CONCLUSIONS: Our results suggest that T cell hyporesponsiveness and polarization of T cell from Th1 to Th2 could be maintained after in vitro mixture of G-PB and G-BM in different proportions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17331846     DOI: 10.1016/j.trim.2006.10.002

Source DB:  PubMed          Journal:  Transpl Immunol        ISSN: 0966-3274            Impact factor:   1.708


  17 in total

Review 1.  Advancement of human leukocyte antigen-partially matched related hematopoietic stem cell transplantation.

Authors:  Xiaodong Mo; Xiaojun Huang
Journal:  Front Med       Date:  2013-07-20       Impact factor: 4.592

2.  Effect of the in vivo application of granulocyte colony-stimulating factor on NK cells in bone marrow and peripheral blood.

Authors:  Xing-Xing Yu; Ting-Ting Han; Ling-Ling Xu; Ying-Jun Chang; Xiao-Jun Huang; Xiang-Yu Zhao
Journal:  J Cell Mol Med       Date:  2018-03-25       Impact factor: 5.310

3.  Causes of mortality after haploidentical hematopoietic stem cell transplantation and the comparison with HLA-identical sibling hematopoietic stem cell transplantation.

Authors:  C H Yan; L P Xu; F R Wang; H Chen; W Han; Yu Wang; J Z Wang; K Y Liu; X J Huang
Journal:  Bone Marrow Transplant       Date:  2015-12-21       Impact factor: 5.483

4.  Good outcome of haploidentical hematopoietic SCT as a salvage therapy in children and adolescents with acquired severe aplastic anemia.

Authors:  Z Wang; X Zheng; H Yan; D Li; H Wang
Journal:  Bone Marrow Transplant       Date:  2014-08-18       Impact factor: 5.483

5.  Modified donor lymphocyte infusion after HLA-mismatched/haploidentical T cell-replete hematopoietic stem cell transplantation for prophylaxis of relapse of leukemia in patients with advanced leukemia.

Authors:  Xiao-Jun Huang; Dai-Hong Liu; Kai-Yan Liu; Lan-Ping Xu; Yu-Hong Chen; Yu Wang; Wei Han; Huan Chen
Journal:  J Clin Immunol       Date:  2008-05       Impact factor: 8.317

6.  Modified donor lymphocyte infusion (DLI) for the prophylaxis of leukemia relapse after hematopoietic stem cell transplantation in patients with advanced leukemia--feasibility and safety study.

Authors:  Xiao-Jun Huang; Yu Wang; Dai-Hong Liu; Lan-Ping Xu; Huan Chen; Yu-Hong Chen; Wei Han; Hong-Xia Shi; Kai-Yan Liu
Journal:  J Clin Immunol       Date:  2008-03-18       Impact factor: 8.317

7.  Stem cell collection in unmanipulated HLA-haploidentical/mismatched related transplantation with combined granulocyte-colony stimulating factor-mobilised blood and bone marrow for patients with haematologic malignancies: the impact of donor characteristics and procedural settings.

Authors:  C Zhang; X-H Chen; X Zhang; L Gao; L Gao; P-Y Kong; X-G Peng; A-H Sun; Y Gong; D-F Zeng; Q-Y Wang
Journal:  Transfus Med       Date:  2010-02-01       Impact factor: 2.019

8.  Quantitative chimerism: an independent acute leukemia prognosis indicator following allogeneic hematopoietic SCT.

Authors:  X-Y Qin; G-X Li; Y-Z Qin; Y Wang; F-R Wang; D-H Liu; L-P Xu; H Chen; W Han; J-Z Wang; X-H Zhang; J-L Li; L-D Li; K-Y Liu; X-J Huang
Journal:  Bone Marrow Transplant       Date:  2014-08-04       Impact factor: 5.483

Review 9.  Modern approaches to HLA-haploidentical blood or marrow transplantation.

Authors:  Christopher G Kanakry; Ephraim J Fuchs; Leo Luznik
Journal:  Nat Rev Clin Oncol       Date:  2015-08-25       Impact factor: 66.675

10.  Haploidentical hematopoietic stem cell transplantation following myeloablative conditioning regimens in hematologic diseases with G-CSF-mobilized peripheral blood stem cells grafts without T cell depletion: a single center report of 38 cases.

Authors:  Rui-Nan Lu; Kou-Rong Miao; Run Zhang; Ming Hong; Ji Xu; Yu Zhu; Hua-Yuan Zhu; Xiao-Yan Qu; Shuai Wang; Li Wang; Lei Fan; Wen-Yi Shen; Hua Lu; Hong-Xia Qiu; Xiao-Yan Zhang; Li-Juan Chen; Wei Xu; Jian-Yong Li; Han-Xin Wu; Si-Xuan Qian
Journal:  Med Oncol       Date:  2014-07-08       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.